Advances in stem cell therapy for premature ovarian failure
10.3760/cma.j.cn101441-20191206-00542
- VernacularTitle:干细胞治疗卵巢早衰研究进展
- Author:
Lijuan WANG
1
;
Xiaolei LIANG
;
Yongxiu YANG
Author Information
1. 兰州大学第一临床医学院 730000
- Publication Type:Journal Article
- Keywords:
Stem cells;
Mesenchymal stem cells;
Premature ovarian insufficiency;
Premature ovarian failure
- From:
Chinese Journal of Reproduction and Contraception
2021;41(1):85-88
- CountryChina
- Language:Chinese
-
Abstract:
Premature ovarian insufficiency (POI) is also known as premature ovarian failure, as one of the main causes of female infertility, and has been widely concerned, mainly manifested by low estrogen levels and high gonadotropin levels. The etiology and mechanism of POI are complex, and there is no consensus at present. With the deepening of stem cell research, stem cell therapy for POI has become a new focus. This paper summarizes the etiology of POI and the mechanism of action of stem cell therapy for POI from different sources, providing reference for future research.